MyFinsight
Home
About
Contact
Back
Income Statement
ELITE PHARMACEUTICALS INC NV (ELTP)
source: myfinsight.com
Download
Download image
Licensing
$433,334
Manufacturing
$39,777,763
Total revenue
$40,211,097
(113.85%↑ Y/Y)
Net (loss) income
-$5,884,715
(-1055.66%↓ Y/Y)
Gross profit
$27,225,970
(221.26%↑ Y/Y)
Cost of
manufacturing
$12,985,127
(25.72%↑ Y/Y)
(loss) income before
income taxes
-$564,214
(-166.55%↓ Y/Y)
Income tax expense
$5,320,501
(2193.53%↑ Y/Y)
Income from operations
$21,699,707
(461.58%↑ Y/Y)
Total operating
expenses
$5,526,263
(19.86%↑ Y/Y)
Other expense, net
-$22,263,921
(-638.12%↓ Y/Y)
Interest income
$4,542
(-15.73%↓ Y/Y)
Non-cash compensation
through issuance of...
$52,329
(0.00%↑ Y/Y)
Depreciation and
amortization
$394,886
(-7.24%↓ Y/Y)
General and
administrative
$3,404,084
(72.87%↑ Y/Y)
Research and development
$1,674,964
(-22.58%↓ Y/Y)
Interest expense and
amortization of debt issuance...
$158,926
(-36.63%↓ Y/Y)
Change in fair value of
derivative financial...
-$22,109,537
(-694.47%↓ Y/Y)
Back